Alkem`s Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.
Lupin receives approval from USFDA for hypertension tablets
Lupin Ltd Generic Azilsartan Kamedoxomil Receives Approval in the U.S.
FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.
FDA Confirms Paragraph IV Patent Litigation for Azilsartan Medoxomil and Chlorthalidomide
Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) azilsartan medoxomil tablets, 40 mg, and 80 mg to market a generic equivalent of Edarbi tablets, 40 mg, and 80 mg, of Arbor Pharmaceuticals, LLC.
Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) azilsartan medoxomil tablets, 40 mg, and 80 mg to market a generic equivalent of Edarbi tablets, 40 mg, and 80 mg, of Arbor Pharmaceuticals, LLC.
FDA is publishing interim acceptable intake levels of nitrosamine impurities in angiotensin II receptor blockers (ARBs) for manufacturers to use to ensure their finished drug products are safe for patients.
India’s drug regulatory force, the Central Drugs Standards Control Organization, pulled off a third round of raids on drug facilities that were manufacturing products without approval.